GlassScriptPhysician profile
Seth Ryan Cohen
NPI 1639279136
$978.88
in general payments reported to CMS, 2019-2025
9 companies · $203 in 2025
The $203 reported for 2025 was more than what 81% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $84.57 · 2021: $28.01 · 2022: $265 · 2023: $271 · 2024: $128 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $601.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $369.65 | 2022-2025 | Acrobat-I Stabilizer, Vasoview Hemopro 2, Heartstring III Proximal Seal |
| Boston Scientific Corporation | $149.24 | 2025 | Farapulse |
| Atricure, INC. | $146.44 | 2020-2022 | |
| Edwards Lifesciences Corporation | $135.69 | 2023 | |
| Janssen Biotech, INC. | $68.85 | 2020 | |
| Janssen Pharmaceuticals, INC | $40.98 | 2021-2022 | |
| Medtronic, INC. | $28.74 | 2024 | Shiley |
| Cardiva Medical, INC. | $21.17 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cvrx, INC. | $18.12 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.